ID   NOM9/TKp53
AC   CVCL_AT84
DR   Wikidata; Q54930896
RX   PubMed=21868764;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AT83 ! NOM9-CT
SX   Male
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
RX   PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690; PMCID=PMC3229662;
RA   Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C.,
RA   Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G.,
RA   Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N.;
RT   "Assembly and initial characterization of a panel of 85 genomically
RT   validated cell lines from diverse head and neck tumor sites.";
RL   Clin. Cancer Res. 17:7248-7264(2011).
//